Brielle Benyon | Authors


Survival in Advanced ESCC Improved With Frontline Nivolumab Plus Ipilimumab or Chemotherapy

July 22, 2021

Improved survival outcomes were reported with the addition of nivolumab to either ipilimumab or chemo-therapy vs chemotherapy alone in the frontline treatment of patients with unresectable advanced or meta-static esophageal squamous cell carcinoma.

Management Strategy Helps to Mitigate Neurotoxicity Concerns With Cilta-Cel in Multiple Myeloma

June 15, 2021

The frequency of neurologic toxicities from ciltacabtagene autoleucel can be reduced with management strategies for patients with relapsed or refractory multiple myeloma treated with the chimeric antigen receptor T-cell therapy, findings from CARTITUDE-2 show.